首页> 外国专利> A DNA Construct that Alters the expression of an endogenous g-csf Gene in a Mammalian Cell in Integration into the cell Genome through homologous derecombinacion,Homologamente Cell stably transfected with a recombinant DNA Construct, a method of altering the expression

A DNA Construct that Alters the expression of an endogenous g-csf Gene in a Mammalian Cell in Integration into the cell Genome through homologous derecombinacion,Homologamente Cell stably transfected with a recombinant DNA Construct, a method of altering the expression

机译:通过同源重组和稳定转染重组DNA构建体的同源基因细胞,改变哺乳动物细胞内源g-csf基因表达并整合到细胞基因组中的DNA构建体,一种改变表达的方法

摘要

A DNA Construct that Alters the expression of an endogenous g-csf Gene in a Mammalian Cell in Integration into the cell Genome through homologous derecombinacion,The Construct includes: (i) a selected Target Sequence that contains at least 20 contiguous nucleotides of SEQ idno.: 5 and (ii) a regulatory sequence of transcription, Cell homologamente stably transfected with a recombinant DNA construct.A method of altering the endogenous g-csf gene expression in a Mammalian Cell, this cell for use in the manufacture of a Medicament.Method of production of g-csf and an isolated Nucleic Acid Molecule.
机译:一种通过同源解整合改变整合到细胞基因组中的哺乳动物细胞中内源性g-csf基因表达的DNA构建体,该构建体包括:(i)包含至少20个SEQ idno连续核苷酸的选定靶序列。 :5和(ii)转录的调控序列,用重组DNA构建体稳定转染的细胞同源物。一种改变哺乳动物细胞中内源性g-csf基因表达的方法,该细胞用于制备药物。 g-csf和分离的核酸分子的生产

著录项

  • 公开/公告号AR016263A1

    专利类型

  • 公开/公告日2001-06-20

    原文格式PDF

  • 申请/专利权人 TRANSKARYOTIC THERAPIES INC.;

    申请/专利号AR1999P102132

  • 发明设计人

    申请日1999-05-06

  • 分类号C12N15/67;C12N15/90;C12N15/85;C12N15/27;C12N5/10;C07K14/535;A61K48/00;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号